Renaissance Technologies LLC
- SEC CIK
- 0001037389
- Latest filing
- Aug 13, 2026
UBX holding history
Unity Biotechnology, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
UBX overviewAll 13F holders of UBXFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −98,311−100.0% | Sold out | Holders |
| Q2 2025 | 98,311 | $37.8K | <0.1% | +4,100+4.4% | Added | Holders |
| Q1 2025 | 94,211 | $98.0K | <0.1% | +17,300+22.5% | Added | Holders |
| Q4 2024 | 76,911 | $75.1K | <0.1% | −16,759−17.9% | Reduced | Holders |
| Q3 2024 | 93,670 | $137.7K | <0.1% | +29,088+45.0% | Added | Holders |
| Q2 2024 | 64,582 | $87.2K | <0.1% | −42,359−39.6% | Reduced | Holders |
| Q1 2024 | 106,941 | $175.0K | <0.1% | +68,770+180.2% | Added | Holders |
| Q4 2023 | 38,171 | $74.0K | <0.1% | −200−0.5% | Reduced | Holders |
| Q3 2023 | 38,371 | $92.0K | <0.1% | −4,100−9.7% | Reduced | Holders |
| Q2 2023 | 42,471 | $108.0K | <0.1% | −35,000−45.2% | Reduced | Holders |
| Q1 2023 | 77,471 | $126.0K | <0.1% | −13,700−15.0% | Reduced | Holders |
| Q4 2022 | 91,171 | $250.0K | <0.1% | −67,066−42.4% | ReducedConverted for a 1-for-10 split | Holders |
| Q3 2022 | 1,582,369 | $625.0K | <0.1% | +624,651+65.2% | Added | Holders |
| Q2 2022 | 957,718 | $540.0K | <0.1% | +51,003+5.6% | Added | Holders |
| Q1 2022 | 906,715 | $1.02M | <0.1% | −170,985−15.9% | Reduced | Holders |
| Q4 2021 | 1,077,700 | $1.57M | <0.1% | +437,000+68.2% | Added | Holders |
| Q3 2021 | 640,700 | $1.92M | <0.1% | +128,100+25.0% | Added | Holders |
| Q2 2021 | 512,600 | $2.38M | <0.1% | +512,600 | New | Holders |